• Self-Amplifying RNA Vaccines for Influenza: Study Insights

  2026-08-18

  A 2026 study found that self-amplifying RNA produced strong, durable, and dose-sparing protection against influenza B in mice, where conventional mRNA performed poorly. Its central contribution is a direct comparison of nucleoside-modified mRNA, self-amplifying RNA, and circular RNA platforms across influenza subtypes.

• Fluorouracil: From DNA Stress to Immune Strategy

  2026-08-18

  A translational perspective on Fluorouracil (5-Fluorouracil, Adrucil), connecting thymidylate synthase inhibition and DNA replication stress with Wnt/β-catenin biology, immune context, and practical oncology research workflows.

• Kir4.1–Panx3 Signaling in Orofacial Neuropathic Pain

  2026-08-17

  This study identifies a mechanistic link between reduced Kir4.1 activity in trigeminal satellite glial cells and Panx3-dependent orofacial neuropathic pain. Using chronic constriction injury of the infraorbital nerve, genetic manipulation, and ROS–p38 MAPK analyses, the authors position Panx3 downstream of a redox-sensitive glial signaling pathway.

• XPO1 Inhibition Sensitizes GCB-DLBCL to Platinum

  2026-08-17

  A 2026 Hematology study shows that inhibiting XPO1 with selinexor increases the response of diffuse large B-cell lymphoma models to cisplatin and oxaliplatin. The strongest combination effects occurred in germinal-center B-cell-like DLBCL, where platinum-associated apoptosis, reactive oxygen species accumulation, DNA-damage signaling, and stress-response pathways were amplified.

• Dinaciclib: From CDK Inhibition to Tissue Mechanics

  2026-08-16

  Explore how Dinaciclib and SCH727965 can support mechanistic cancer research beyond conventional cell-cycle assays. This article connects multi-CDK inhibition with apoptosis, Rb signaling, and the interpretation of tissue-boundary phenotypes revealed by quantitative developmental biology.

• Dual-Action p38α Inhibitors and Dephosphorylation

  2026-08-15

  The reference study shows that selected kinase inhibitors can both suppress p38α catalytic activity and accelerate WIP1-mediated removal of the activation-loop phosphate. Biochemical measurements and X-ray structures connect this effect to stabilization of a phosphatase-accessible activation-loop conformation, suggesting a framework for designing more durable and selective kinase inhibitors.

• Anisomycin Workflows for JNK Signaling Studies

  2026-08-14

  Anisomycin provides a practical pharmacological entry point for separating early JNK signaling from later cell death phenotypes. This guide covers concentration and timing screens, cancer-apoptosis applications, neurobiology extensions, and controls that prevent stress-response data from being overinterpreted.

• Olaparib: A G4–PARP Combination Framework

  2026-08-14

  Olaparib and AZD2281 are examined as mechanistic tools for connecting PARP inhibition with the BLM G-quadruplex–STAT1 axis. This framework helps researchers design more informative DNA damage response assays, combination studies, and tumor radiosensitization experiments.

• Astrocytic GAT-3 Controls Dentate Gyrus Memory

  2026-08-13

  Shen and colleagues show that astrocytic GAT-3 converts GABA uptake into a calcium-dependent signal that enhances dentate gyrus synaptic transmission through presynaptic GluN2B-containing NMDARs. The study connects this glial pathway to contextual fear memory and provides a mechanistic framework for synaptic transmission research and related in vitro neurotransmission assays.

• Anisomycin, JNK Signaling, and Translational Strategy

  2026-08-13

  Anisomycin is more than a cytotoxicity reagent: it is a mechanistic JNK agonist that can help translational researchers connect stress signaling, apoptosis, and experimental decision-making. This article places its cancer biology applications alongside emerging lessons from social memory research while clearly separating established evidence from forward-looking hypotheses.

• Acacetin, Mitophagy, and Pyroptosis in IVDD

  2026-08-12

  A 2025 Phytomedicine study identifies an acacetin-mediated MAPK1/HMOX1 pathway through which Duhuo Jisheng decoction enhances mitophagy and suppresses nucleus pulposus cell pyroptosis in intervertebral disc degeneration. Its integrated chemical, cellular, and animal-model design provides a useful framework for connecting traditional medicine components with mitochondrial quality control and inflammatory cell death.

• Adefovir (GS-0393) in HBV Research

  2026-08-12

  Adefovir combines a mechanistically clear HBV polymerase readout with a useful OAT1 transporter application, enabling antiviral and renal-disposition workflows from one research tool. This guide covers dose-response design, aqueous handling, transporter kinetics, and interpretation of hypophosphatemia-related translational signals.

• Dual-Action Inhibitors Reprogram p38α Dephosphorylation

  2026-08-11

  The 2024 preprint identifies kinase inhibitors that do more than suppress p38α catalytic signaling: they also accelerate WIP1-mediated removal of the activation-loop phosphothreonine. Biochemical measurements and X-ray structures suggest that inhibitor-stabilized activation-loop conformations expose the phosphatase substrate, providing a framework for designing kinase inhibitors that promote pathway shutdown through two coordinated mechanisms.

• BH3-Mimetics Target Apoptotic Vulnerability in GBM

  2026-08-11

  Koessinger and colleagues show that glioblastoma, including patient-derived stem-like cells, is unusually dependent on anti-apoptotic BCL-XL and MCL-1. Their data support sequential BH3-mimetic targeting as a way to exploit apoptotic priming and generate anti-tumor responses in experimental GBM models.

• Anisomycin and JNK: A Memory Assay Framework

  2026-08-10

  Anisomycin is more than a JNK agonist for apoptosis studies: it can serve as a pathway-level perturbation in carefully controlled investigations of synaptic memory maintenance. This article connects JNK signaling to the neuroligin 1 proteolysis mechanism while defining the controls needed to avoid confusing pathway activation with causal proof.

16700 records 1/1114 page Next 12345 下5页 Last page